The Cancer Research Institute (CRI), the Association for Cancer lmmunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to present the Fourth International Cancer lmmunotherapy Conference.

The 2018 meeting will take place at the New York Marriott Marquis in New York, New York, USA from September 30-October 3, 2018. The program will focus on "Translating Science into Survival," and feature talks from more than 50 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy, including: regulating T cells and their response to cancer, tumor microenvironment, genetically engineered T cells, maintenance of immune balance, novel vaccine platforms and combinations, mutational analysis and predicting response to immunotherapy, convergence of technology and cancer immunotherapy, microbiome, and metabolism. 

This meeting will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates.


While we encourage your use of social media in and around the conference, we ask that you be aware of the following guidelines:

  • Follow the conference organizers on Twitter (@CancerResearch, @C_IMT, and @AACR) and use the hashtag #cicon18 for this conference.

  • Conference attendees may share information from presentations on social media provided that they respect the wishes of presenters. Oral presenters may label any or all slides in their presentations with “DO NOT POST.” Similarly, poster presenters may label their posters with “DO NOT POST.” Attendees must respect the presenters’ requests in these instances and refrain from posting any images from these designated slides or posters on social media.


  • Conference attendees may take photographs during oral or poster presentations provided that the photographs are strictly for personal, noncommercial use and are not to be published in any form. Attendees are prohibited from using flash photography or otherwise distracting the presenters or members of the audience.

  • The New York Marriott Marquis is 100% smoke-free; smoking within the hotel is prohibited.

  • Children under 12 years of age are not permitted in any scientific session or poster session at any time. Children cannot be left unattended or unsupervised.

  • Cell phones, pagers, and other electronic devices must be turned off or placed on “silent” mode before entering a session.

  • Lost and Found: Attendees may contact the conference Registration Desk for any lost items.

  • Poster presenters are solely responsible for placing their poster on the assigned poster board and removing their poster according to the schedule provided. The conference organizers cannot be responsible for any posters that are not removed at the designated time. Posters left in the Poster Hall after that time may be discarded.

  • Poster presenters should not leave any items at their poster board unattended, including poster tubes, meeting bags, Programs, personal items, etc. The conference organizers are not responsible for any items left in the Poster Hall.



The American Association for Cancer Research (AACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.


AACR has designated this live activity for a maximum of 23.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. (Dr. Sahin’s talk is not available for CME).

Credit certification for individual sessions may vary, dependent upon compliance with the ACCME Accreditation Criteria. The final number of credits may vary from the maximum number indicated above.


Physicians and other health care professionals seeking AMA PRA Category 1 Credit(s)TM for this live continuing medical education activity must complete the online CME Request for Credit Survey (available in September) by Wednesday, November 14, 2018. Certificates will only be issued to those who complete the survey.  Your CME certificate will be sent to you via email after the completion of the activity.

View the Disclosure of Financial Relationships related to this CME activity. 

PLanning Committee Members

Conference Co-Chairpersons

  • Nina Bhardwaj, Icahn School of Medicine at Mount Sinai, New York, NY

  • Christoph Huber, Association for Cancer Immunotherapy (CIMT), Mainz, Germany

  • Elizabeth M. Jaffee, Johns Hopkins School of Medicine, Baltimore, MD

  • Guido Kroemer, Centre de Recherche des Cordeliers, Paris, France

scientific planning committee

  • Carl G. Figdor, Radboud University Nijmegen, Nijmegen, The Netherlands

  • Wolf H. Fridman, Centre de Recherche des Cordeliers, Paris, France

  • Crystal L. Mackall, Stanford University School of Medicine, Stanford, CA

  • Cornelis J. M. Melief, Leiden University Medical Center & ISA Pharmaceuticals, Leiden, The Netherlands

  • Drew M. Pardoll, Johns Hopkins School of Medicine, Baltimore, MD

  • Ellen Puré, University of Pennsylvania, Philadelphia, PA

  • Catherine Sautès-Fridman, Université Paris-Descartes, Paris, France

  • Ton Schumacher, The Netherlands Cancer Institute, Leiden, The Netherlands

  • Giorgio Trinchieri, National Cancer Institute, Bethesda, MD

  • Özlem Türeci, BioNTech AG, Mainz, Germany

  • Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY

  • Laurence Zitvogel, Institut Gustave Roussy, Paris, France